Your browser doesn't support javascript.
loading
P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.
Sinadinos, Anthony; Young, Christopher N J; Al-Khalidi, Rasha; Teti, Anna; Kalinski, Pawel; Mohamad, Shafini; Floriot, Léonore; Henry, Tiphaine; Tozzi, Gianluca; Jiang, Taiwen; Wurtz, Olivier; Lefebvre, Alexis; Shugay, Mikhail; Tong, Jie; Vaudry, David; Arkle, Stephen; doRego, Jean-Claude; Górecki, Dariusz C.
Affiliation
  • Sinadinos A; Molecular Medicine, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom.
  • Young CN; Molecular Medicine, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom.
  • Al-Khalidi R; Molecular Medicine, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom.
  • Teti A; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Kalinski P; Departments of Surgery, Immunology, and Bioengineering, School of Medicine, University of Pittsburgh, Pittsburg, Pennsylvania, United States of America.
  • Mohamad S; School of Engineering, University of Portsmouth, Portsmouth, United Kingdom.
  • Floriot L; Platform of Behavioural Analysis (SCAC), University of Rouen, Mont-Saint-Aignan,Rouen, France.
  • Henry T; Platform of Behavioural Analysis (SCAC), University of Rouen, Mont-Saint-Aignan,Rouen, France.
  • Tozzi G; School of Engineering, University of Portsmouth, Portsmouth, United Kingdom.
  • Jiang T; Molecular Medicine, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom.
  • Wurtz O; INSERM U982, Plate-Forme d'Imagerie PRIMACEN, IRIB, University of Rouen, Mont-Saint-Aignan, France.
  • Lefebvre A; Platform of Behavioural Analysis (SCAC), University of Rouen, Mont-Saint-Aignan,Rouen, France.
  • Shugay M; Genomics of Adaptive Immunity Lab, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry and Pirogov Russian National Research Medical University, Moscow, Russia.
  • Tong J; School of Engineering, University of Portsmouth, Portsmouth, United Kingdom.
  • Vaudry D; INSERM U982, Plate-Forme d'Imagerie PRIMACEN, IRIB, University of Rouen, Mont-Saint-Aignan, France.
  • Arkle S; Molecular Medicine, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom.
  • doRego JC; Platform of Behavioural Analysis (SCAC), University of Rouen, Mont-Saint-Aignan,Rouen, France; National Center of Scientific Research (CNRS), Caen, France.
  • Górecki DC; Molecular Medicine, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom.
PLoS Med ; 12(10): e1001888, 2015 Oct.
Article in En | MEDLINE | ID: mdl-26461208
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Muscular Dystrophy, Duchenne / Receptors, Purinergic P2X7 Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals Language: En Journal: PLoS Med Journal subject: MEDICINA Year: 2015 Document type: Article Affiliation country: United kingdom Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Muscular Dystrophy, Duchenne / Receptors, Purinergic P2X7 Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals Language: En Journal: PLoS Med Journal subject: MEDICINA Year: 2015 Document type: Article Affiliation country: United kingdom Country of publication: United States